• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马拉维有和没有合并症或危险体征的小儿吸气性肺炎。

Malawian children with chest-indrawing pneumonia with and without comorbidities or danger signs.

机构信息

University of Washington, Seattle, Washington, USA.

University of North Carolina Project, Lilongwe Medical Relief Fund Trust, Lilongwe, Malawi.

出版信息

J Glob Health. 2021 Mar 7;11:04016. doi: 10.7189/jogh.11.04016.

DOI:10.7189/jogh.11.04016
PMID:33791095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7979154/
Abstract

BACKGROUND

Children with comorbidities or danger signs are often excluded from trials evaluating pneumonia treatment.

METHODS

We sought to investigate whether the percentage of children with chest-indrawing pneumonia cured at Day 14 was lower among those with HIV infection or exposure, malaria, moderate or severe acute malnutrition, or anemia enrolled in a prospective observational cohort study than among children without these comorbidities enrolled in a concurrent prospective randomized controlled trial evaluating duration of amoxicillin treatment in Lilongwe, Malawi.

RESULTS

Children with chest-indrawing pneumonia and comorbidities but without danger signs did not have statistically significant higher treatment failure rates by Day 6 than those in the chest-indrawing pneumonia clinical trial. However, children with chest-indrawing pneumonia and HIV infection or exposure, malaria, or moderate or severe acute malnutrition had higher rates of not being clinically cured at Day 14 when compared to children without these comorbidities (adjusted differences ranging from 7.7% to 17.0%). Furthermore, among children without danger signs at enrollment, but with HIV infection or HIV exposure or moderate or severe acute malnutrition, 12.5% and 15.6% respectively were not clinically cured at Day 14 even though they were without treatment failure by Day 6.

CONCLUSIONS

More intensive follow-up of children with chest-indrawing pneumonia and comorbidities who do not have danger signs may be beneficial.

摘要

背景

患有合并症或危险体征的儿童通常被排除在评估肺炎治疗效果的试验之外。

方法

我们试图研究在马拉维利隆圭开展的一项前瞻性观察性队列研究中,与未患有这些合并症的儿童相比,感染艾滋病毒或接触艾滋病毒、疟疾、中重度急性营养不良或贫血的伴有胸腔凹陷性肺炎的儿童在第 14 天治愈的比例是否较低,这些儿童入组于评估阿莫西林治疗时间的同时进行的前瞻性随机对照试验。

结果

患有胸腔凹陷性肺炎合并症但无危险体征的儿童,在第 6 天的治疗失败率与胸腔凹陷性肺炎临床试验中的儿童相比,没有统计学上的显著升高。然而,与无这些合并症的儿童相比,患有胸腔凹陷性肺炎且感染艾滋病毒或接触艾滋病毒、疟疾或中重度急性营养不良的儿童在第 14 天未达到临床治愈的比例更高(调整后的差异范围为 7.7%至 17.0%)。此外,在入组时无危险体征但感染艾滋病毒或艾滋病毒接触或中重度急性营养不良的儿童中,分别有 12.5%和 15.6%在第 14 天未达到临床治愈,尽管他们在第 6 天没有治疗失败。

结论

对无危险体征的伴有胸腔凹陷性肺炎合并症的儿童进行更密切的随访可能是有益的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee2/7979154/cb9a39102964/jogh-11-04016-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee2/7979154/09822a62937e/jogh-11-04016-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee2/7979154/cb9a39102964/jogh-11-04016-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee2/7979154/09822a62937e/jogh-11-04016-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dee2/7979154/cb9a39102964/jogh-11-04016-F2.jpg

相似文献

1
Malawian children with chest-indrawing pneumonia with and without comorbidities or danger signs.马拉维有和没有合并症或危险体征的小儿吸气性肺炎。
J Glob Health. 2021 Mar 7;11:04016. doi: 10.7189/jogh.11.04016.
2
Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol.马拉维利隆圭 2 至 59 月龄儿童胸部凹陷性肺炎采用阿莫西林分散片 3 天与 5 天疗法进行双盲随机对照临床试验的方法:研究方案。
BMC Infect Dis. 2018 Sep 21;18(1):476. doi: 10.1186/s12879-018-3379-z.
3
Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children.阿莫西林治疗马拉维儿童肺炎性胸腔积液 3 天或 5 天的疗效比较
N Engl J Med. 2020 Jul 2;383(1):13-23. doi: 10.1056/NEJMoa1912400.
4
Clinical Outcomes of Pneumonia and Other Comorbidities in Children Aged 2-59 Months in Lilongwe, Malawi: Protocol for the Prospective Observational Study "Innovative Treatments in Pneumonia".马拉维利隆圭2至59个月儿童肺炎及其他合并症的临床结局:前瞻性观察研究“肺炎创新治疗”方案
JMIR Res Protoc. 2019 Jul 29;8(7):e13377. doi: 10.2196/13377.
5
Malawian children with fast-breathing pneumonia with and without comorbidities.患有快速呼吸性肺炎且伴有或不伴有合并症的马拉维儿童。
Pneumonia (Nathan). 2021 Feb 25;13(1):3. doi: 10.1186/s41479-021-00081-y.
6
Community case management of lower chest indrawing pneumonia with oral amoxicillin in children in Kenya.肯尼亚儿童口服阿莫西林治疗下胸部凹陷性肺炎的社区病例管理。
Acta Paediatr. 2018 Dec;107 Suppl 471:44-52. doi: 10.1111/apa.14405.
7
Innovative, enhanced community management of non-hypoxaemic chest-indrawing pneumonia in 2-59-month-old children: a cluster-randomised trial in Africa and Asia.创新性、强化的社区管理对 2-59 月龄儿童非低氧性吸气性肺炎的效果:在非洲和亚洲的一项整群随机试验
BMJ Glob Health. 2022 Jan;7(1). doi: 10.1136/bmjgh-2021-006405.
8
Which children with chest-indrawing pneumonia can be safely treated at home, and under what conditions is it safe to do so? A systematic review of evidence from low- and middle-income countries.哪些有鸡胸肺炎的儿童可以安全地在家中治疗,以及在什么条件下可以安全地这样做?来自中低收入国家的证据的系统评价。
J Glob Health. 2022 Aug 31;12:10008. doi: 10.7189/jogh.12.10008.
9
Factors predicting mortality in hospitalised HIV-negative children with lower-chest-wall indrawing pneumonia and implications for management.预测住院的HIV阴性下胸壁凹陷性肺炎患儿死亡率的因素及其对治疗的影响。
PLoS One. 2024 Mar 11;19(3):e0297159. doi: 10.1371/journal.pone.0297159. eCollection 2024.
10
Repeat assessment of physical examination findings among HIV-uninfected children in Malawi with chest-indrawing pneumonia: Recto: Chest-indrawing pneumonia in HIV-uninfected.
Int J Infect Dis. 2021 Sep;110:371-373. doi: 10.1016/j.ijid.2021.07.073. Epub 2021 Jul 31.

引用本文的文献

1
Prevalence and outcome of anemia among children hospitalized for pneumonia and their risk of mortality in a developing country.发展中国家儿童因肺炎住院的贫血患病率和结局及其死亡风险。
Sci Rep. 2022 Jun 24;12(1):10741. doi: 10.1038/s41598-022-14818-2.

本文引用的文献

1
Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children.阿莫西林治疗马拉维儿童肺炎性胸腔积液 3 天或 5 天的疗效比较
N Engl J Med. 2020 Jul 2;383(1):13-23. doi: 10.1056/NEJMoa1912400.
2
Clinical Outcomes of Pneumonia and Other Comorbidities in Children Aged 2-59 Months in Lilongwe, Malawi: Protocol for the Prospective Observational Study "Innovative Treatments in Pneumonia".马拉维利隆圭2至59个月儿童肺炎及其他合并症的临床结局:前瞻性观察研究“肺炎创新治疗”方案
JMIR Res Protoc. 2019 Jul 29;8(7):e13377. doi: 10.2196/13377.
3
Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study.
无 HIV 感染的非洲和亚洲儿童需住院治疗的严重肺炎的病因:PERCH 多国家病例对照研究。
Lancet. 2019 Aug 31;394(10200):757-779. doi: 10.1016/S0140-6736(19)30721-4. Epub 2019 Jun 27.
4
Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol.马拉维利隆圭 2 至 59 月龄儿童胸部凹陷性肺炎采用阿莫西林分散片 3 天与 5 天疗法进行双盲随机对照临床试验的方法:研究方案。
BMC Infect Dis. 2018 Sep 21;18(1):476. doi: 10.1186/s12879-018-3379-z.
5
Chest Radiograph Findings in Childhood Pneumonia Cases From the Multisite PERCH Study.多中心PERCH研究中儿童肺炎病例的胸部X光片检查结果
Clin Infect Dis. 2017 Jun 15;64(suppl_3):S262-S270. doi: 10.1093/cid/cix089.
6
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Clinical and Hypoxemic Childhood Pneumonia over Three Years in Central Malawi: An Observational Study.13价肺炎球菌结合疫苗对马拉维中部儿童三年临床及低氧血症性肺炎的影响:一项观察性研究
PLoS One. 2017 Jan 4;12(1):e0168209. doi: 10.1371/journal.pone.0168209. eCollection 2017.
7
Mortality and its risk factors in Malawian children admitted to hospital with clinical pneumonia, 2001-12: a retrospective observational study.马拉维儿童因临床肺炎住院的死亡率及其危险因素:一项回顾性观察研究。2001-12 年
Lancet Glob Health. 2016 Jan;4(1):e57-68. doi: 10.1016/S2214-109X(15)00215-6.
8
Hypoxaemia as a Mortality Risk Factor in Acute Lower Respiratory Infections in Children in Low and Middle-Income Countries: Systematic Review and Meta-Analysis.低氧血症作为低收入和中等收入国家儿童急性下呼吸道感染的死亡风险因素:系统评价与荟萃分析
PLoS One. 2015 Sep 15;10(9):e0136166. doi: 10.1371/journal.pone.0136166. eCollection 2015.
9
Risk factors for mortality from acute lower respiratory infections (ALRI) in children under five years of age in low and middle-income countries: a systematic review and meta-analysis of observational studies.低收入和中等收入国家五岁以下儿童急性下呼吸道感染(ALRI)死亡的危险因素:观察性研究的系统评价和荟萃分析
PLoS One. 2015 Jan 30;10(1):e0116380. doi: 10.1371/journal.pone.0116380. eCollection 2015.
10
Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis.2000-13 年全球、区域和国家儿童死亡原因及其对 2015 年后重点的影响:更新系统分析。
Lancet. 2015 Jan 31;385(9966):430-40. doi: 10.1016/S0140-6736(14)61698-6. Epub 2014 Sep 30.